US$ 20.22
upcoming glp-1 drugs What to Make of the Coverage and Cost Landscape GLP-1 Drug Savings: A Complete
Description
Once the data is sufficiently acceptable the cost-benefit analysis for the insurers is impossible to ignore they will begin covering these drugs widely, and the benefit to the patients will show up in terms of savings

[DOI] [PubMed] [Google Scholar] 100.Polakis P

Compared to GLP-1 RAs, SGLT2is (WMD: 0.43

Nature 653 , 770775 (2026)

The price is good
